+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030- Product Image
Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030- Product Image
Sale

Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015208
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biocompatibility Testing Market grew from USD 3.13 billion in 2024 to USD 3.42 billion in 2025. It is expected to continue growing at a CAGR of 9.09%, reaching USD 5.29 billion by 2030.

Understanding the Vital Role of Biocompatibility Testing in Medical Device Innovation

Biocompatibility testing stands at the forefront of medical device innovation, ensuring that every material, component, and finished product interacts safely with human tissue. From early-phase cytotoxicity assays to elaborate in vivo evaluations, each test type plays a critical role in shielding patients from potential adverse reactions. The era of rapid prototyping and personalized devices has elevated the importance of rigorous genotoxicity and hemocompatibility assessments alongside conventional irritation, pyrogenicity, and sensitization protocols. Within cytotoxicity alone, techniques such as agar diffusion, elution tests, and MTT assays provide nuanced insights into cellular responses. As devices evolve in complexity and material science pushes boundaries, the introduction of advanced materials like composites, ceramics, elastomers, metals, and polymers demands a holistic testing framework. This introduction lays the foundation for understanding how regulatory mandates, emerging technologies, and shifting market forces converge to redefine safety benchmarks and accelerate product development timelines.

Decoding the Transformative Shifts Redefining Biocompatibility Testing

Over the past decade, a convergence of regulatory refinement, technological breakthroughs, and clinical demand has transformed the biocompatibility testing landscape. High-resolution microscopy and chromatography advances have elevated analytical techniques, enabling detection of trace impurities that once eluded standard protocols. Simultaneously, computational modeling platforms now predict tissue-material interactions before a single in vitro assay begins, reducing reliance on animal testing and expediting data cycles. In vitro platforms have matured from basic cell viability screens into organ‐on‐chip systems that replicate complex physiological microenvironments. In vivo methodologies, enriched by high-definition imaging, yield deeper insights into systemic responses over long-term implantation studies. Meanwhile, harmonized standards under ISO 10993, ASTM, and USP have paved the way for global submissions, while contract research organizations and academic institutions expand capacity to meet surging demand. This transformative shift underscores a transition from isolated test protocols toward an integrated, data-driven ecosystem that accelerates innovation while maintaining uncompromised safety.

Assessing the Cumulative Impact of United States Tariffs on Testing Operations

The 2025 tranche of United States tariffs has introduced new cost pressures and operational complexities for manufacturers and testing laboratories alike. Import levies on raw metallic alloys and high-grade polymers have reverberated through the supply chain, inflating material costs at the point of test sample preparation. Manufacturers face higher outlays for ceramics and composite substrates, while contract research organizations contend with surging procurement expenses for chromatographic columns and spectroscopic reagents. These cumulative tariff effects have led to readjusted pricing strategies, with service providers allocating a greater share of budgets to customs duties and logistics. In response, in house facilities are optimizing batch processing of irritation, pyrogenicity, and sensitization studies to absorb fixed costs. Meanwhile, select segments of the industry are negotiating bulk import agreements and exploring nearshore partnerships to mitigate duties on equipment critical for in vitro and computational modeling workflows. The net impact has been a realignment of cost structures rather than a reduction in testing rigor, reinforcing the sector’s resilience.

Unveiling Critical Segmentation Insights Driving Test Market Dynamics

A deep dive into segmentation reveals nuanced drivers that shape market trajectories. Test type influences laboratory workflows, as the choice among cytotoxicity platforms-whether agar diffusion, elution test, or MTT assay-alters throughput and resource allocation. Genotoxicity and hemocompatibility studies attract specialized instrumentation, while multifunctional irritation and sensitization evaluations demand cross-disciplinary expertise. End-use applications steer priorities: cardiovascular devices impose stringent hemocompatibility thresholds, dental and ophthalmic products require precise irritation assessments, and orthopedic implants rely heavily on wear-induced pyrogenicity screening. Material selection further differentiates demand, with ceramics commanding robust analytical workflows and polymers prompting expanded in vitro testing regimes. Technique adoption varies between labs favoring traditional analytical procedures like chromatography, microscopy, and spectroscopy and those embracing computational modeling or advanced in vivo models. Testing standards, whether ASTM, ISO 10993, or USP protocols, dictate validation pathways and influence time to market. Service provider type also shapes innovation cycles: academic institutions propel early-stage method development, in house teams drive proprietary assay refinement, and contract research organizations scale high-volume projects.

Mapping Regional Variations Shaping Biocompatibility Testing Demand

Regional dynamics exert a profound influence on testing demand and regulatory alignment. In the Americas, markets benefit from well-established ISO 10993 frameworks and robust contract research ecosystems, catalyzing rapid iteration of cardiovascular and orthopedic device portfolios. Europe, the Middle East and Africa display a tapestry of regulatory convergence under the Medical Device Regulation, with emerging hubs prioritizing localized evaluation of ceramics and composites destined for dental and ophthalmic applications. In Asia-Pacific, manufacturing expansions fuel demand for polymers and elastomers analysis, while evolving in vitro capabilities in major economies accelerate adoption of organ-on-chip platforms. Each region’s emphasis on specific technique clusters-whether advanced spectroscopy in the Americas, microscopy innovations in EMEA, or computational modeling in Asia-Pacific-reflects the interplay of local infrastructure, funding priorities, and clinical needs. Collectively, these regional insights illuminate where capacity is scaling, where regulatory bodies are tightening oversight, and where service providers should channel investments to capture emerging opportunities.

Illuminating Competitive Landscapes Through Key Company Profiles

Leading industry players are driving differentiation through strategic investments in technology and partnerships. Selected contract research organizations are expanding their portfolios to include integrated in vitro and computational modeling services, positioning themselves at the nexus of predictive toxicology. Major testing laboratories are upgrading infrastructure to offer high-throughput cytotoxicity assays while refining elution and agar diffusion techniques for novel biomaterials. In house teams within device manufacturers are forging alliances with academic institutions to co-develop bespoke irritation and genotoxicity protocols, accelerating data generation for regulatory filings. Innovators in analytical techniques have launched next-generation chromatography columns and spectroscopy probes tailored to trace-level impurity detection. At the same time, service providers adhering to ASTM, ISO 10993, and USP standards are harmonizing validation processes across multiple geographies, smoothing the path to global market entry. These company-level insights highlight how forward-looking organizations are reinforcing safety pipelines, enhancing efficiency, and cultivating trust among regulatory authorities and end-users.

Strategic Imperatives for Industry Leaders Navigating Biocompatibility Testing

Industry leaders must embrace strategic imperatives to thrive in a dynamic biocompatibility testing ecosystem. First, diversifying testing platforms by integrating computational modeling with in vitro assays can reduce time to insight and lower reliance on quotas for in vivo studies. Second, negotiating flexible tariff pass-through agreements and exploring localized reagent production will mitigate cost volatility introduced by import duties. Third, aligning R&D roadmaps with evolving international standards under ASTM, ISO 10993, and USP ensures smoother regulatory approvals and faster revenue realization. Fourth, cultivating collaborative pipelines between academic institutions, contract research organizations, and in house facilities will accelerate method development, knowledge transfer, and capacity scaling. Finally, prioritizing investments in advanced analytical technologies-such as next-generation microscopy and chromatography-will unlock higher resolution data and strengthen safety dossiers. By adopting these recommendations, organizations can navigate uncertainties, optimize resource deployment, and deliver safer, more effective medical devices to market.

Transparent Methodology Underpinning Robust Market Analysis

Our research methodology combines rigorous secondary research with targeted primary interviews to deliver a robust analysis of the biocompatibility testing market. Secondary sources encompass regulatory databases, peer-reviewed journals, standards body publications, and industry whitepapers to establish a comprehensive baseline of historical trends, material innovation, and regulatory evolution. Primary inputs derive from discussions with senior toxicologists, quality assurance leaders, laboratory directors, and materials scientists, providing firsthand insights into emerging challenges and opportunities. Data validation follows a triangulation process, whereby quantitative findings are crosschecked against qualitative feedback to ensure consistency. Market segmentation frameworks are defined through iterative consultation, capturing test type variances, end-use application profiles, material characteristics, technique adoption rates, testing standard adherence, and service provider roles. Regional dynamics are assessed by aligning policy updates with on-the-ground capacity assessments and investment flows. This transparent and repeatable methodology underpins our conclusions, delivering actionable intelligence for decision makers.

Conclusion Highlighting Strategic Perspectives for Stakeholders

In conclusion, the biocompatibility testing landscape is undergoing profound transformation, driven by evolving regulatory standards, material innovations, and technological breakthroughs. Tariff pressures in the United States have prompted operational recalibrations without compromising safety protocols, while segmentation insights illuminate where specialized expertise and infrastructure yield competitive advantage. Regional nuances reveal distinct growth corridors across the Americas, Europe, the Middle East and Africa, and Asia-Pacific, each demanding tailored strategies. Leading companies are forging strategic partnerships, scaling advanced analytical capabilities, and harmonizing global validation pathways to remain at the vanguard of device safety assessments. The recommendations outlined herein offer a clear roadmap to harness emerging opportunities, optimize cost structures, and accelerate time to market. As the industry continues to evolve, stakeholders equipped with comprehensive, data-driven insights will be best positioned to deliver innovative, safe, and effective medical devices worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Cytotoxicity
      • Agar Diffusion
      • Elution Test
      • Mtt Assay
    • Genotoxicity
    • Hemocompatibility
    • Irritation
    • Pyrogenicity
    • Sensitization
  • End-Use Application
    • Cardiovascular Devices
    • Dental Devices
    • Ophthalmic Devices
    • Orthopedic Implants
    • Wound Care
  • Material Type
    • Ceramics
    • Composites
    • Elastomers
    • Metals
    • Polymers
  • Technique
    • Analytical Techniques
      • Chromatography
      • Microscopy
      • Spectroscopy
    • Computational Modeling
    • In Vitro Testing
    • In Vivo Testing
  • Testing Standard
    • Astm Standards
    • Iso 10993
    • Usp Standards
  • Service Provider
    • Academic Institutions
    • Contract Research Organizations
    • In House Facilities
    • Testing Laboratories
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Eurofins Scientific SE
  • SGS SA
  • Intertek Group plc
  • Bureau Veritas SA
  • TÜV SÜD AG
  • TÜV Rheinland AG
  • Nelson Laboratories, LLC
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • WuXi AppTec Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biocompatibility Testing Market, by Test Type
8.1. Introduction
8.2. Cytotoxicity
8.2.1. Agar Diffusion
8.2.2. Elution Test
8.2.3. Mtt Assay
8.3. Genotoxicity
8.4. Hemocompatibility
8.5. Irritation
8.6. Pyrogenicity
8.7. Sensitization
9. Biocompatibility Testing Market, by End-Use Application
9.1. Introduction
9.2. Cardiovascular Devices
9.3. Dental Devices
9.4. Ophthalmic Devices
9.5. Orthopedic Implants
9.6. Wound Care
10. Biocompatibility Testing Market, by Material Type
10.1. Introduction
10.2. Ceramics
10.3. Composites
10.4. Elastomers
10.5. Metals
10.6. Polymers
11. Biocompatibility Testing Market, by Technique
11.1. Introduction
11.2. Analytical Techniques
11.2.1. Chromatography
11.2.2. Microscopy
11.2.3. Spectroscopy
11.3. Computational Modeling
11.4. In Vitro Testing
11.5. In Vivo Testing
12. Biocompatibility Testing Market, by Testing Standard
12.1. Introduction
12.2. Astm Standards
12.3. Iso 10993
12.4. Usp Standards
13. Biocompatibility Testing Market, by Service Provider
13.1. Introduction
13.2. Academic Institutions
13.3. Contract Research Organizations
13.4. In House Facilities
13.5. Testing Laboratories
14. Americas Biocompatibility Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biocompatibility Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biocompatibility Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Eurofins Scientific SE
17.3.2. SGS SA
17.3.3. Intertek Group plc
17.3.4. Bureau Veritas SA
17.3.5. TÜV SÜD AG
17.3.6. TÜV Rheinland AG
17.3.7. Nelson Laboratories, LLC
17.3.8. Charles River Laboratories International, Inc.
17.3.9. Covance Inc.
17.3.10. WuXi AppTec Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOCOMPATIBILITY TESTING MARKET MULTI-CURRENCY
FIGURE 2. BIOCOMPATIBILITY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. BIOCOMPATIBILITY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOCOMPATIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOCOMPATIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOCOMPATIBILITY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY AGAR DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ELUTION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MTT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY GENOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY HEMOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IRRITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY PYROGENICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SENSITIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ELASTOMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY METALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COMPUTATIONAL MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ASTM STANDARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ISO 10993, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY USP STANDARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN HOUSE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 67. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 116. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 128. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 129. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 138. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 140. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 144. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 145. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 146. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 148. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 151. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 153. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 178. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 184. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 185. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 194. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 196. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 199. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 201. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 204. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 207. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 208. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 209. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 223. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 224. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 227. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 228. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 230. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 232. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 233. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 234. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 235. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 236. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 239. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 240. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 241. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 252. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 254. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 257. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 258. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 259. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 260. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 262. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 263. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 264. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 265. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 283. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 284. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 285. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 287. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 288. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 289. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 290. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 291. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 293. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 296. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 297. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 298. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 299. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 301. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 304. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 305. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 306. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 322.

Companies Mentioned

The companies profiled in this Biocompatibility Testing market report include:
  • Eurofins Scientific SE
  • SGS SA
  • Intertek Group plc
  • Bureau Veritas SA
  • TÜV SÜD AG
  • TÜV Rheinland AG
  • Nelson Laboratories, LLC
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.29 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioceramics Market Report by Material, Biocompatibility, Application, and Region 2025-2033 - Product Image

Bioceramics Market Report by Material, Biocompatibility, Application, and Region 2025-2033

  • Report
  • 147 Pages
  • Global
From
Biomaterial Testing Equipment Market by Testing Technology, Test Type, Material Type, Application, End User - Global Forecast to 2030 - Product Image

Biomaterial Testing Equipment Market by Testing Technology, Test Type, Material Type, Application, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Biocompatibility and Performance of Medical Devices - Product Image

Biocompatibility and Performance of Medical Devices

  • Book
  • 540 Pages
Biocompatibility and Performance of Medical Devices. Edition No. 2. Woodhead Publishing Series in Biomaterials - Product Image

Biocompatibility and Performance of Medical Devices. Edition No. 2. Woodhead Publishing Series in Biomaterials

  • Book
Biocompatible 3D Printing Material Market by Material Type, Printing Technology, Application, End User, Product Form - Global Forecast to 2030 - Product Image

Biocompatible 3D Printing Material Market by Material Type, Printing Technology, Application, End User, Product Form - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.